ALB and Cirrhosis: The recent ATTIRE trial (A Randomized Trial of Albumin Infusions in Hospitalized Patients with Cirrhosis; ISRCT number, N14174793) which randomized hospitalized patients with decompensated cirrhosis to prophylactic albumin infusion and standard of care showed that there was no significant difference in the incidence of kidney dysfunction between both groups of patients [50].